IP Library › Granted Patent US 8,063,043
Granted Patent B2
US 8,063,043 · App. 13/061,572 · Granted Nov 22, 2011

Salts of N-[6-cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4′-(trifluoromethoxy)[1,1′-biphenyl]-3-carboxamide

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,063,043
App. No.
13/061,572
Granted
Nov 22, 2011
Kind
B2
Abstract

Salts of N-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4′-(trifluoromethoxy)[1,1′-biphenyl]-3-carboxamide are prepared and characterized.

Claims (4)

1. A diphosphate salt of N-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4′-(trifluoromethoxy)[1,1′-biphenyl]-3-carboxamide.

2. A pharmaceutical composition comprising:

(a) a therapeutically effective amount of a salt according to claim 1 ; and

(b) at least one pharmaceutically acceptable carrier, diluent, vehicle or excipient.

Assignments (3)
MERGER Recorded Feb 15, 2023
From: SUN PHARMA GLOBAL FZE
To: SUN PHARMACEUTICAL INDUSTRIES LIMITED
Reel/Frame 062709/0922 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2017
From: NOVARTIS AG
To: SUN PHARMA GLOBAL FZE
Reel/Frame 041537/0215 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2011
From: BAJWA, JOGINDER SINGH; DE LA CRUZ, MARILYN; DODD, STEPHANIE KAY; WAYKOLE, LILADHAR MURLIDHAR; WU, RAEANN
To: NOVARTIS AG
Reel/Frame 025927/0756 →